arrow_back Back Filing freshness 20-F Q4 FY2025 SEC EDGAR

YD Bio Ltd

YDES
$2.33 ▼ -0.06 (-2.71%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
4 Visible periods
5 Metrics
Peer-ranked Benchmarks
Price Chart
90
Health
Excellent
Bullish
auto_awesome

Analytical Summary

YD Bio Ltd shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap
Dividend Yield
Revenue Growth
Op. Margin
ROIC
FCF / Share
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 5, 2026.
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
100
Cash Quality
64

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 4 years · 4 quarters